Clinical Trials
10 results for Bladder Cancer
Molecular Correlates of Sensitivity and Resistance to Therapy in Genitourinary Malignancy
- Condition: Healthy Control, Localized Urothelial Carcinoma of the Renal Pelvis and Ureter, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter, Recurrent Bl
- Intervention: Other: Cytology Specimen Collection Procedure, Other: Laboratory Biomarker Analysis
- Study ID: NCT01050504
Recombinant Human Interleukin-7 to Promote T-Cell Recovery After Cord Blood Transplantation
- Condition: Leukemia, Lymphoma, Myeloma, Myeloproliferative Diseases
- Intervention: Drug: Busulfan, Drug: Fludarabine, Drug: Clofarabine, Drug: Rabbit ATG, Radiation: Total Body Irradiation (TBI), Procedure: Cord Blood Infusions, Drug: Rituximab, Drug: Cyclophosphamide, Procedure: Natural Killer Cell Infusion, Drug: Melphalan, Drug: Mesna
- Study ID: NCT02727803
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney
- Condition: Urothelial Cancer, Cancer, Bladder Neoplasms, Urinary Bladder Cancer
- Study ID: NCT00872495
Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancer
- Condition: Urinary Bladder Tumour
- Study ID: NCT06087016
Association of Perioperative Cognitive Dysfunction With Circulating Biomarkers of Neurological Damage in Patients Underging Transurethral Resection of Bladder Tumor
- Condition: Cognitive Decline, Urinary Bladder Cancer, Frail, Biomarker, General Anesthesia, Hand Grip Strength, Cognitive Testing, Comorbidities, Demographic Data, Socio-economic Status, Perioperative Complications
- Study ID: NCT07165236
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
- Condition: Urothelial Carcinoma (UC), Bladder (Urothelial, Transitional Cell) Cancer, Liquid Biopsy
- Study ID: NCT07441499
Study Protocol for Evaluating the Efficacy of Anti-HER-2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
- Condition: Bladder Cancer
- Study ID: NCT07379268
Detection of CREPT Expression in Exfoliated Urothelial Cells for Early Diagnosis and Recurrence Monitoring of Bladder Cancer
- Condition: Bladder Cancer
- Study ID: NCT07514897
Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle
- Condition: Bladder Cancer
- Study ID: NCT07545694
T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer, an Exploratory Non-intervention Study.
- Condition: Bladder Cancer
- Study ID: NCT07581496